Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Idle Evening Thoughts

<< Previous

Bullboard Posts

Next >>

Comment by pelabooston Dec 13, 2023 8:08pm

205 Views

Post# 35783490

RE:RE:Idle Evening Thoughts

It appears that MC now has 350K new options at $1.91. I am not defending him, but he lets the 12/13 options expire and does not have to lay out any cash. He has 350K newly minted options and in the event of a buyout greater than $1.91 he has a guarantee even if he lays out cash for the options at $1.91.

I do understand your point about not exercising. So we will have to wait and see what the market thinks.

I really would like to be doing something else, and hope this does not drag out much longer.

Cheers

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec